Clinical Trials · NCT04513704
A Clinical Trial Comparing Semaglutide in Healthy People Who Eat and Take the Medicine at Different Times
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 156
- Start date
- Aug 2020
- Locations
- 1 site, United Kingdom
- Primary endpoint
- Area under the semaglutide plasma concentration - time curve during a dosing interval after the 10th dosing (AUC0-24h,sema,day10)